ALLOGENE THERAPEUTICS INC shareholders Q3 2023

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MetLife Investment Management, LLC 42,018$133,1970.00%
Tower Research Capital LLC (TRC) 8,249$26,1490.00%
EP Wealth Advisors, LLC 10,850$34,3950.00%
Arizona State Retirement System 24,915$78,9810.00%
VANGUARD GROUP INC 10,587,804$33,563,3380.00%
Ameritas Investment Partners, Inc. 8,104$25,6900.00%
TD ASSET MANAGEMENT INC 237,836$753,9400.00%
HORIZON KINETICS ASSET MANAGEMENT LLC 20,000$63,4000.00%
SCHRODER INVESTMENT MANAGEMENT GROUP 168,864$535,2990.00%
RHUMBLINE ADVISERS 139,145$441,0730.00%
PRINCIPAL FINANCIAL GROUP INC 266,154$843,7080.00%
Itau Unibanco Holding S.A. 4,699$14,8960.00%
Man Group plc 82,700$262,1590.00%
Squarepoint Ops LLC 121,792$386,0810.00%
QUADRANT CAPITAL GROUP LLC 3,590$11,3810.00%
AMERICAN INTERNATIONAL GROUP, INC. 41,012$130,0080.00%
METROPOLITAN LIFE INSURANCE CO/NY 4,341$13,7610.00%
NORTHERN TRUST CORP 860,527$2,727,8710.00%
GROUP ONE TRADING, L.P. 55,159$174,8540.00%
GEODE CAPITAL MANAGEMENT, LLC 2,071,353$6,567,1310.00%
External links

This page lists ALLOGENE THERAPEUTICS INC's shareholders in Q3 2023. To view ALLOGENE THERAPEUTICS INC's shareholder history, click here.